Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

A new treatment using special microneedles and a nitric oxide-releasing drug could improve hair growth and be more convenient for people with hair loss.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

TNF-a may not be as involved in certain types of hair loss as previously thought.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

The laser treatment effectively and safely reduces post-acne redness in adult Chinese patients.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Apremilast did not work for treating severe alopecia areata.

A portable device can create nanofibers to improve the appearance of thinning hair better than commercial products.

The argon gas-based cryotherapy effectively reduced keloid scars but caused some hypopigmentation and had a recurrence rate, especially in Afro-American patients.

Red and infrared light therapy improves hair growth in balding patients.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Lacrimal gland inflammation and alopecia areata can happen together due to autoimmune issues.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.

A man regrew hair after using a 2% fluorouracil treatment on his scalp.

Combining microdermabrasion with steroid injections improves hair regrowth in scalp alopecia areata.

Frontal fibrosing alopecia on limbs shows permanent inflammatory hair loss, not typical scarring.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.